R. Reynolds

First name

R.

Middle name

F.

Last name

Reynolds

Hennessy, S., Bilker, W. B., Knauss, J. S., Kimmel, S. E., Margolis, D. J., Morrison, M. F., et al. (2004). Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol. Br J Clin Pharmacol. http://doi.org/10.1111/j.1365-2125.2004.02098.x

View

Abbing-Karahagopian, V., Kurz, X., de Vries, F., van Staa, T. P., Alvarez, Y., Hesse, U., et al. (2014). Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol.

View

Wing, K., Douglas, I., Bhaskaran, K., Klungel, O. H., Reynolds, R. F., Pirmohamed, M., et al. (2014). Development of predictive genetic tests for improving the safety of new medicines: the utilization of routinely collected electronic health records. Drug Discov Today. http://doi.org/10.1016/j.drudis.2013.11.003

View

Wing, K., Bhaskaran, K., Smeeth, L., van Staa, T. P., Klungel, O. H., Reynolds, R. F., & Douglas, I. (2016). Optimising case detection within UK electronic health records: use of multiple linked databases for detecting liver injury. BMJ Open. http://doi.org/10.1136/bmjopen-2016-012102

View

Huerta, C., Abbing-Karahagopian, V., Requena, G., Oliva, B., Alvarez, Y., Gardarsdottir, H., et al. (2016). Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3825

View

Wing, K., Bhaskaran, K., Pealing, L., Root, A., Smeeth, L., van Staa, T. P., et al. (2017). Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study. J Antimicrob Chemother. http://doi.org/10.1093/jac/dkx183

View